H.R. 10887

Protecting Consumer Access to Generic Drugs Act of 2026

Sponsor: Seth Magaziner · 0 cosponsors

Follow this bill

Official summary

No official summary yet.

Text of the bill

Expand all
Sec. 5. Commission litigation authority

Section 16(a)(2) of the Federal Trade Commission Act (15 U.S.C. 56(a)(2)) is amended—

(1) in subparagraph (D), by striking or after the semicolon;

(2) in subparagraph (E), by inserting or after the semicolon; and

(3) by inserting after subparagraph (E) the following:

Text this section adds to the law

(F) under section 2(d)(3)(A) of the Protecting Consumer Access to Generic Drugs Act of 2026;